Medical tourists often face opaque pricing, unverified providers, informal intermediaries and fragmented support, while CureMeAbroad says its accreditation checks, AI cost estimator, clinical matching and patient assistance are designed to make cross-border care more trusted and transparent. Its October 2026 $1.1 million pre-seed round led by SteerX Ventures is aimed at expanding the accredited hospital network, source markets, AI technology and teams; the company reports more than 22,500 monthly visitors, a $4.8 million current annual patient-booking run rate and a $100 million FY2028 target.